In HCC, protein methyltransferase 6 (PRMT6) suppressed its cancer stemness properties through the methylation of CRAF on arginine 100, thus disrupting the binding between CRAF and RAS, which, in turn, suppressed the MEK/ERK axis [44]. This evidence concerns the gene RAF1 and hepatocellular carcinoma.